1. Home
  2. KGS vs RGEN Comparison

KGS vs RGEN Comparison

Compare KGS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kodiak Gas Services Inc.

KGS

Kodiak Gas Services Inc.

HOLD

Current Price

$64.92

Market Cap

6.8B

Sector

N/A

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$146.60

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KGS
RGEN
Founded
2011
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
6.6B
IPO Year
2023
1995

Fundamental Metrics

Financial Performance
Metric
KGS
RGEN
Price
$64.92
$146.60
Analyst Decision
Strong Buy
Buy
Analyst Count
7
12
Target Price
$57.17
$167.67
AVG Volume (30 Days)
1.7M
947.4K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
2.93%
N/A
EPS Growth
58.93
286.96
EPS
0.20
0.15
Revenue
$1,308,100,000.00
$141,236,000.00
Revenue This Year
$12.30
$14.30
Revenue Next Year
$7.96
$14.52
P/E Ratio
$330.00
$988.07
Revenue Growth
12.83
35.10
52 Week Low
$30.06
$100.99
52 Week High
$77.68
$175.77

Technical Indicators

Market Signals
Indicator
KGS
RGEN
Relative Strength Index (RSI) 41.39 62.57
Support Level $55.10 $141.44
Resistance Level $77.13 $149.05
Average True Range (ATR) 2.99 5.08
MACD -0.58 0.16
Stochastic Oscillator 11.50 75.28

Price Performance

Historical Comparison
KGS
RGEN

About KGS Kodiak Gas Services Inc.

Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. The company manages its business through two operating segments: Contract Services and Other Services. Contract Services consists of operating company-owned and customer-owned compression, gas treating, and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings. Maximum revenue for the company is generated from its Contract Services segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: